Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
Recruiting · NCT06067295 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of Southern California
View the official record on ClinicalTrials.gov →Interventions studied
Non-Interventional Study
What this trial is about
This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collecting biological samples (like blood, urine, and tissue), and health information (such as treatment, diet, and quality of life) researchers hope to learn more about prostate cancer and ways to improve outcomes in the future.
Who can take part
Age range
18 Years and older
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Men of all racial and ethnic groups 18 years of age or older
- Men with a diagnosis of advanced (metastatic) prostate cancer who are scheduled to begin a new systemic treatment (including first or subsequent lines of therapy)
- Prior participation on clinical trials is allowed
Exclusion criteria
- Inability to give informed consent
- Any other malignancy, unless previously treated with curative intent and the subject has been disease free for 3 years or longer
Where it is running
2 locations listed across 1 US state.
- Los Angeles General Medical Center - Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center - Los Angeles, California, United States